Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 2500
Single User License Price INR 175000
Corporate User License Price USD 7500
Corporate User License Price INR 525000
Site License Price USD 5000
Site License Price INR 350000
Request a Quote

Report Title

Acute Pain Global Clinical Trials Review, H1, 2017

Quote Request for License Type
License Type Price  
Single User License USD 2500
Site License USD 5000
Enterprise Wide License USD 7500
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Acute Pain Global Clinical Trials Review, H1, 2017


Quote Request for License Type
License Type Price  
Single User License USD 2500
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Acute Pain Global Clinical Trials Review, H1, 2017

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Acute Pain Global Clinical Trials Review, H1, 2017



Executive Summary

Acute Pain Global Clinical Trials Review, H1, 2017

Summary

GlobalData's clinical trial report, "Acute Pain Global Clinical Trials Review, H1, 2017" provides an overview of Acute Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Report Guidance 4

Clinical Trials by Region 5

Clinical Trials and Average Enrollment by Country 6

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9

Top Five Countries Contributing to Clinical Trials in Europe 10

Top Countries Contributing to Clinical Trials in North America 11

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12

Top Five Countries Contributing to Clinical Trials in Central and South America 13

Clinical Trials by G7 Countries: Proportion of Acute Pain to Central Nervous System Clinical Trials 14

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 18

Clinical Trials by E7 Countries: Proportion of Acute Pain to Central Nervous System Clinical Trials 20

Clinical Trials by Phase in E7 Countries 22

Clinical Trials in E7 Countries by Trial Status 23

Clinical Trials by Phase 25

In Progress Trials by Phase 26

Clinical Trials by Trial Status 27

Clinical Trials by End Point Status 29

Subjects Recruited Over a Period of Time 30

Clinical Trials by Sponsor Type 31

Prominent Sponsors 32

Top Companies Participating in Acute Pain Therapeutics Clinical Trials 34

Prominent Drugs 36

Latest Clinical Trials News on Acute Pain 37

Feb 21, 2017: Trevena Announces Positive Top-line Results from Two Phase 3 Pivotal Efficacy Studies of Intravenous Oliceridine in Moderate-to-Severe Acute Pain 37

Feb 13, 2017: AcelRx Pharmaceuticals Presentation at JAB Burn Symposium Highlights Potential of DSUVIA for Use in Burn Victims with Moderate-to-Severe Acute Pain 38

Jan 04, 2017: Trevena Completes Enrollment of Phase 3 APOLLO Pivotal Efficacy Trials of Oliceridine for Moderate-to-Severe Acute Pain 39

Dec 06, 2016: AcelRx Pharmaceuticals Reports on ARX-04 Market and Landscape Presented at Analyst & Investor Event 39

Nov 29, 2016: KemPharm Receives Clearance from FDA to Initiate Clinical Program for KP201/IR, a Single-Entity Benzhydrocodone HCl Immediate Release Abuse-Deterrent Prodrug for the Treatment of Acute Pain 40

Clinical Trial Profile Snapshots 41

Appendix 340

Abbreviations 340

Definitions 340

Research Methodology 341

Secondary Research 341

About GlobalData 342

Contact Us 342

Disclaimer 342

Source 343

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Acute Pain Therapeutics, Global, Clinical Trials by Region (%), 2017* 5

Acute Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 6

Acute Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8

Acute Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 9

Acute Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10

Acute Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 11

Acute Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 12

Acute Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 13

Proportion of Acute Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 14

Acute Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16

Acute Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18

Proportion of Acute Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 20

Acute Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 22

Acute Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 23

Acute Pain Therapeutics, Global, Clinical Trials by Phase (%), 2017* 25

Acute Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 26

Acute Pain Therapeutics, Global, Clinical Trials by Trial Status, 2017* 27

Acute Pain Therapeutics Clinical Trials, Global, by End Point Status, 2017* 29

Acute Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 30

Acute Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 31

Acute Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 32

Acute Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 34

Acute Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 36

GlobalData Methodology 341

List of Tables

Acute Pain Therapeutics, Global, Clinical Trials by Region, 2017* 5

Acute Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7

Acute Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8

Acute Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 9

Acute Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10

Acute Pain Therapeutics Clinical Trials, North America, Top Countries, 2017* 11

Acute Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 12

Acute Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 13

Proportion of Acute Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 15

Acute Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17

Acute Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19

Proportion of Acute Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 21

Acute Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 22

Acute Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 24

Acute Pain Therapeutics, Global, Clinical Trials by Phase, 2017* 25

Acute Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 26

Acute Pain Therapeutics, Global, Clinical Trials by Trial Status, 2017* 28

Acute Pain Therapeutics Clinical Trials, Global, by End Point Status, 2017* 29

Acute Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 30

Acute Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 31

Acute Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 33

Acute Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 35

Acute Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 36

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Mallinckrodt Plc, Pfizer Inc, Grunenthal GmbH, Johnson & Johnson, Trevena Inc, Merck & Co Inc, AcelRx Pharmaceuticals Inc, Lotus Clinical Research LLC, Mundipharma International Ltd, Cara Therapeutics Inc


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person